Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,973.9
0.9 (0.03%)

 

  • STI Straits Times Index
    2,973.9
    0.9 (0.03%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,569.9
    2.7 (0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,095.9
    -356.7 (-1.21%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,508.6
    -42.8 (-1.21%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,408.2
    -255.3 (-0.86%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,359.2
    20.7 (0.33%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,401.8M
  • Value: 1,563.7M
  • Rise: 135
  • Fall: 228
  • Unch: 411

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.064-0.008
CWX Global0.005-0.001
Advanced Systems0.001-
Thomson Medical0.117-0.004
Jiutian Chemical0.087-0.003
QT Vascular0.008+0.001
Anchor Resources0.015-
Sembcorp Marine0.153-
ThaiBev0.725-0.010
Jasper Inv0.005-0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,588.8 +396.5
HSI 29,095.9 -356.7
HSCEI 11,361.4 -92.3
Jakarta 6,359.2 +20.7
Nikkei 225 29,408.2 -255.3
SSE Comp 3,508.6 -42.8
Shanghai A 3,677.7 -44.9
Shanghai B 245.7 -0.4
KOSPI 3,043.9 +30.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AUSTRALIAN PRIMARY HEMP LTD AUSTRALIAN PRIMARY HEMP
Updated on 02 Mar 2021 (End of trading day)
Last (AUD): 0.435 Change: +0.045 High: 0.435 Remarks: -
Change (%): +11.54 Low: 0.400
Open 0.400 Yesterday's Close 0.39
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 93,448 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.06186 Trailing EPS (AUD) e -0.06186 NAV (AUD) b 0.0287
PE a - Trailing PE f - Price / NAV b 15.1568
Dividend (AUD) d - Cash In Hand (AUD) g 0.0245 Issued & Paid-up Shares c 95,605,100
Dividend Yield (%) d - Price / Cash In Hand g 17.755 Treasury Shares h -
Beta - 75 Daysi 0.328 R-Squared - 75 Days(%)i 0.24 Market Cap (M) 41.588
Beta - 500 Daysi 0.392 R-Squared - 500 Days (%)i 0.18 Enterprise Value (M) 40.869
Piotroski F Score 0 Exchange Code APH Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 147.23 Free Float (%) 71.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 15 Oct 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AUSTRALIAN PRIMARY HEMP LTD ASX 41.588 - - 15.1568 -
Industry Biotechnology ASX 3,355.840 46.746 38.275 11.0314 1.020
Local Peer CSL LTD ASX 122,734.937 39.133 32.250 11.6146 1.088
Local Peer POLYNOVO LIMITED ASX 1,627.014 - - 68.3333 -
Local Peer MESOBLAST LTD ASX 1,366.764 - - 1.8192 -
Local Peer TELIX PHARMACEUTIC ASX 1,132.249 - - 14.3009 -
Local Peer OPTHEA LIMITED ASX 545.327 - - 2.7597 -
Local Peer IMUGENE LIMITED ASX 475.960 - - - -
Local Peer ANTEOTECH LIMITED ASX 383.381 - - 62.1212 -
Local Peer BIONOMICS LTD ASX 264.688 - - - -
Local Peer NEXT SCIENCE LTD ASX 242.751 - - 9.9049 -
Local Peer IMMUTEP LTD ASX 227.054 - - -28.0000 -
Local Peer KAZIA THERAPEUTICS LIMITED ASX 167.057 - - - -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 152.890 - - 6.3168 -
Other Local Peers LEAF RESOURCES LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 131,130.585 18.052 18.052 13.9367 2.822
Global Peer GILEAD SCIENCES INC NASDAQ 78,486.611 638.128 638.103 4.3120 4.346
Global Peer ILLUMINA INC NASDAQ 65,144.350 99.305 99.305 13.8782 -
Global Peer MODERNA INC NASDAQ 62,923.798 - - 24.3168 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 54,690.385 20.169 20.169 6.2958 -
Global Peer WUXI BIO HKEx 420,172.970 365.501 291.805 28.1277 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 49,607.459 14.120 14.120 4.4994 -
Global Peer BIOGEN INC NASDAQ 41,624.289 10.405 10.405 3.8900 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 33,410.301 55.370 55.370 2.8675 -
Global Peer BEIGENE HKEx 227,641.261 - - 7.5877 -
Other Global Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), 10X GENOMICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ZAI LAB-SB (HKEx), BRIDGEBIO PHARMA INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), BEAM THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), JOINN (HKEx), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), FIBROGEN INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), VERACYTE INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), GENSCRIPT BIO (HKEx), NANTKWEST INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), SEER INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), VIELA BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), 3SBIO (HKEx), ARCUS BIOSCIENCES INC (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALLOVIR INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NUVATION BIO INC (NYSE), STOKE THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MYOVANT SCIENCES LTD (NYSE), KYMERA THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), JW THERAP-B (HKEx), NGM BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), JACOBIO-B (HKEx), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), OCUGEN INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), VOR BIOPHARMA INC (NASDAQ), REGENXBIO INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOATLA INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ALPHAMAB-B (HKEx), ZENTALIS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), IMMUNOGEN INC (NASDAQ), PRECIGEN INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), VIVA BIOTECH (HKEx), FREQUENCY THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), IMMUNOVANT INC (NASDAQ), PERSONALIS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ALECTOR INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), HAOHAI BIOTEC (HKEx), RHYTHM PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), VAXCYTE INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), JHBP-B (HKEx), OMEROS CORP (NASDAQ), MIMEDX GROUP INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), INHIBRX INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), PASSAGE BIO INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), HUMANIGEN INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), VAXART INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), MERUS B V (NASDAQ), CURIS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CHIMERIX INC (NASDAQ), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), COMPUGEN (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), AKOUOS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), IMMATICS N V (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AFFIMED N V (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ATRECA INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), MOLECULAR TEMPLATES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), ALTIMMUNE INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), SINOMAB BIO-B (HKEx), MAGENTA THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), DPHARMA (Bursa), SPRUCE BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AVROBIO INC (NASDAQ), ADICET BIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), SESEN BIO INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), IMMUNOME INC (NASDAQ), VERASTEM INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), XOMA CORP (NASDAQ), ESSEX BIO-TECH (HKEx), ONCORUS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), APTOSE BIOSCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), PARATEK PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NEXTCURE INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), MEDICINOVA INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), METACRINE INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), IMV INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CHIASMA INC (NASDAQ), INMUNE BIO INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CEL-SCI CORP (NYSE American), DIAMEDICA THERAPEUTICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ORGENESIS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), IBIO INC (NYSE American), GENOCEA BIOSCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LONGEVERON INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), LA JOLLA PHARMACEUTICAL CO (NASDAQ), OTONOMY INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ARAVIVE INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CAPRICOR THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), DIFFUSION PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), SAVARA INC (NASDAQ), COHBAR INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), ORGANOVO HLDGS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), RECRO PHARMA INC (NASDAQ), UNI-BIO GROUP (HKEx), CLEVELAND BIOLABS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), REGENT PACIFIC (HKEx), VIRACTA THERAPEUTICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), ORAGENICS INC (NYSE American), ATYR PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), PRECIPIO INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CT ENTERPRISE (HKEx), ACHIEVE LIFE SCIENCE INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), Suntar Eco-City (SGX), HISTOGEN INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.030
-6.45 %
10 Days --0.060
-12.12 %
20 Days -+0.010
+2.35 %
Medium Term Return 3 Months -+0.095
+27.94 %
6 Months -+0.305
+234.62 %
1 Year -+0.300
+222.22 %
Annualised Return Annualised --
+222.22 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.049 - 0.620 Change From 1 Year Low +0.386 % Change From 1 Year Low (%) +787.76
Change From 1 Year High -0.185 % Change From 1 Year High (%) -29.84
2 Years Range 0.049 - 0.620 Change From 2 Years Low +0.386 % Change From 2 Years Low (%) +787.76
Change From 2 Years High -0.185 % Change From 2 Years High (%) -29.84
5 Years Range 0.049 - 0.620 Change From 5 Years Low +0.386 % Change From 5 Years Low (%) +787.76
Change From 5 Years High -0.185 % Change From 5 Years High (%) -29.84
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Australian Primary Hemp Ltd. is a biotechnology company, which engages in developing new human therapeutics based on its proprietary drug discovery, drug targeting and synthesis technologies. It involves in the research and development of new human pharmaceuticals. The company also engages in the commercialization and improvements of its generic fondaparinux product. Its products include fondaparinux sodium, hyact and ha-irinotecan. Australian Primary Hemp was founded by James Hood and Tracie Rams dale in 1995 and is headquartered in Newtown, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
02 Mar 2021 0.400 0.435 0.400 0.435 93,448 -
01 Mar 2021 0.410 0.420 0.390 0.390 186,738 -
26 Feb 2021 0.430 0.430 0.410 0.410 145,842 -
25 Feb 2021 0.460 0.460 0.425 0.430 152,859 -
24 Feb 2021 0.465 0.470 0.455 0.465 101,072 -
23 Feb 2021 0.480 0.480 0.460 0.465 112,336 -
22 Feb 2021 0.460 0.480 0.460 0.480 95,406 -
19 Feb 2021 0.465 0.465 0.450 0.455 79,281 -
18 Feb 2021 0.480 0.480 0.430 0.455 268,284 -
17 Feb 2021 0.495 0.495 0.470 0.490 59,923 -
16 Feb 2021 0.480 0.495 0.480 0.495 80,406 -
15 Feb 2021 0.490 0.500 0.460 0.465 151,216 -
12 Feb 2021 0.500 0.515 0.470 0.480 185,959 -
11 Feb 2021 0.515 0.540 0.490 0.495 363,725 -
10 Feb 2021 0.500 0.510 0.485 0.500 267,670 -
09 Feb 2021 0.500 0.520 0.480 0.480 382,852 -
08 Feb 2021 0.470 0.550 0.465 0.495 925,671 -
05 Feb 2021 0.455 0.460 0.425 0.435 44,577 -
04 Feb 2021 0.450 0.450 0.435 0.450 149,244 -
03 Feb 2021 0.430 0.460 0.430 0.450 82,798 -
02 Feb 2021 0.465 0.475 0.420 0.425 187,799 -
01 Feb 2021 0.470 0.470 0.425 0.430 240,669 -
Summary
Current 2 Weeks
(17 Feb 2021 to 02 Mar 2021)
0.495 0.495 0.390 0.435 1,295,189 -
Previous 2 Weeks
(03 Feb 2021 to 16 Feb 2021)
0.430 0.495 0.390 0.495 2,634,118 -
4 Weeks from
(05 Jan 2021 to 02 Feb 2021)
0.355 0.495 0.345 0.425 5,565,563 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.